ZA200403024B - Pharmaceutically acceptable alendronate salts in amorphous form. - Google Patents

Pharmaceutically acceptable alendronate salts in amorphous form.

Info

Publication number
ZA200403024B
ZA200403024B ZA200403024A ZA200403024A ZA200403024B ZA 200403024 B ZA200403024 B ZA 200403024B ZA 200403024 A ZA200403024 A ZA 200403024A ZA 200403024 A ZA200403024 A ZA 200403024A ZA 200403024 B ZA200403024 B ZA 200403024B
Authority
ZA
South Africa
Prior art keywords
pharmaceutically acceptable
amorphous form
acceptable alendronate
salts
alendronate salts
Prior art date
Application number
ZA200403024A
Other languages
English (en)
Inventor
Yusuf Khwaja Hamied
Dharmaraj Ramachandra Rao
Rajendra Narayanrao Kankan
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9924125&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200403024(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of ZA200403024B publication Critical patent/ZA200403024B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200403024A 2001-10-18 2004-04-21 Pharmaceutically acceptable alendronate salts in amorphous form. ZA200403024B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0125081A GB2383042A (en) 2001-10-18 2001-10-18 Amorphous alendronate sodium

Publications (1)

Publication Number Publication Date
ZA200403024B true ZA200403024B (en) 2005-03-30

Family

ID=9924125

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200403024A ZA200403024B (en) 2001-10-18 2004-04-21 Pharmaceutically acceptable alendronate salts in amorphous form.

Country Status (22)

Country Link
US (1) US7112577B2 (pt)
EP (1) EP1436303B1 (pt)
JP (1) JP4490100B2 (pt)
KR (1) KR20040053186A (pt)
AT (1) ATE338761T1 (pt)
AU (1) AU2002334200B2 (pt)
BR (1) BR0213398A (pt)
CA (1) CA2463815C (pt)
CL (1) CL2004001372A1 (pt)
DE (1) DE60214576T2 (pt)
EC (1) ECSP045067A (pt)
ES (1) ES2271375T3 (pt)
GB (1) GB2383042A (pt)
HK (1) HK1066011A1 (pt)
IL (1) IL161360A0 (pt)
MX (1) MXPA04003549A (pt)
NZ (1) NZ532292A (pt)
PT (1) PT1436303E (pt)
RU (1) RU2334751C2 (pt)
TN (1) TNSN04067A1 (pt)
WO (1) WO2003033508A1 (pt)
ZA (1) ZA200403024B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0215413A (pt) * 2001-12-24 2004-12-14 Teva Pharma Formula dosada com um comprimido central de ingrediente ativo encapado em uma capa anular prensada de material em pó ou granulado e processo e conjunto de ferramentas para a sua produção
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
ITMI20020146A1 (it) * 2002-01-29 2003-07-29 Lyogen Ltd Alendronato monosodico amorfo e processo per la sua preparazione
WO2005082915A1 (en) † 2004-02-26 2005-09-09 Zentiva, A.S. Amorphous forms of risedronate monosodium
ES2289650T3 (es) 2004-03-03 2008-02-01 Chemi S.P.A. Sal monosodica del acido 3-piridil-1-hidroxietiliden-1,1-bifosfonico amorfa y procedimiento para la preparacion de la misma.
CZ297262B6 (cs) * 2004-12-28 2006-10-11 Zentiva, A. S. Trisodná sul kyseliny 4-amino-1-hydroxybutyliden-1,1-bisfosfonové
US20090118238A1 (en) * 2007-09-17 2009-05-07 Protia, Llc Deuterium-enriched alendronate
WO2014043208A1 (en) 2012-09-11 2014-03-20 Medivation Prostate Therapeutics, Inc. Formulations of enzalutamide
BR112015005404A2 (pt) * 2012-09-11 2017-08-22 Dr Reddys Laboratories Ltd Formas polimórficas de enzalutamida e sua preparação
US11447506B2 (en) 2016-05-09 2022-09-20 Anacor Pharmaceuticals, Inc. Crystal forms of crisaborole in free form and preparation method and use thereof
CA3023851C (en) * 2016-05-09 2021-01-26 Anacor Pharmaceuticals, Inc. Crystal forms of crisaborole in free form and preparation method and use thereof
CN109311905A (zh) * 2016-06-16 2019-02-05 泽农医药公司 螺-吲哚酮化合物的固态形式
US10717715B2 (en) * 2016-09-06 2020-07-21 Indena S.P.A. Solid forms of ingenol 3-(3,5-diethylisoxazole-4-carboxylate) and method for preparing the same
PT3512863T (pt) 2016-09-07 2022-03-09 Atea Pharmaceuticals Inc Nucleótidos de purina 2'-substituídos-n6-substituídos para tratamento de vírus de rna
US11369579B2 (en) 2016-10-24 2022-06-28 Syneurx International (Taiwan) Corp. Polymorphic forms of sodium benzoate and uses thereof
US10336679B2 (en) * 2016-10-24 2019-07-02 Syneurx International (Taiwan) Corp. Polymorphic forms of sodium benzoate and uses thereof
KR102335193B1 (ko) * 2017-02-01 2021-12-03 아테아 파마슈티컬즈, 인크. C형 간염 바이러스를 치료하기 위한 뉴클레오티드 헤미-술페이트 염
WO2018178133A1 (en) * 2017-03-30 2018-10-04 Merck Patent Gmbh Solid form of (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)methanol
ES2959764T3 (es) * 2017-11-22 2024-02-28 Agios Pharmaceuticals Inc Formas cristalinas de n-(4-(4-(ciclopropilmetil) piperazina-1-carbonil)fenil)quinolina-8-sulfonamida
CN112351799A (zh) 2018-04-10 2021-02-09 阿堤亚制药公司 具有硬化的hcv感染患者的治疗
US10874687B1 (en) 2020-02-27 2020-12-29 Atea Pharmaceuticals, Inc. Highly active compounds against COVID-19
WO2022176017A1 (ja) * 2021-02-16 2022-08-25 大塚製薬株式会社 非晶質体及び当該非晶質体を含む組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4304734A (en) * 1980-10-16 1981-12-08 Vysoka Skola Chemicko-Technologicka 6-Amino-1-hydroxyhexylidene diphosphonic acid, salts and a process for production thereof
US4922007A (en) * 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
ATE289199T1 (de) * 1995-06-06 2005-03-15 Merck & Co Inc Formulierungen mit dem wasserfreien mononatriumsalz von alendronat und deren verwendung zur behandlung von knochenkrankheiten
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
CZ2001629A3 (cs) 1998-08-27 2001-08-15 Teva Pharmaceutical Industries Ltd. Nové formy hydrátů alendronátu sodného, způsob jejich výroby a farmaceutické kompozice na jejich bázi
US6160165A (en) * 1998-12-10 2000-12-12 Aesgen, Inc. Method for preparation of disodium pamidronate
EP1135397B1 (en) 1998-12-10 2003-04-23 Aesgen, Inc. Method for preparation of disodium pamidronate
WO2001030788A1 (en) 1999-10-26 2001-05-03 A/S Gea Farmaceutisk Fabrik Novel salts of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid, their preparation and use

Also Published As

Publication number Publication date
ECSP045067A (es) 2004-07-23
CA2463815C (en) 2009-04-07
AU2002334200B2 (en) 2008-04-03
EP1436303A1 (en) 2004-07-14
ES2271375T3 (es) 2007-04-16
GB2383042A (en) 2003-06-18
WO2003033508A1 (en) 2003-04-24
NZ532292A (en) 2005-07-29
MXPA04003549A (es) 2004-07-22
DE60214576T2 (de) 2007-08-30
DE60214576D1 (de) 2006-10-19
RU2004113306A (ru) 2005-10-10
HK1066011A1 (en) 2005-03-11
US7112577B2 (en) 2006-09-26
RU2334751C2 (ru) 2008-09-27
JP4490100B2 (ja) 2010-06-23
ATE338761T1 (de) 2006-09-15
IL161360A0 (en) 2004-09-27
PT1436303E (pt) 2006-12-29
EP1436303B1 (en) 2006-09-06
BR0213398A (pt) 2005-01-11
CA2463815A1 (en) 2003-04-24
KR20040053186A (ko) 2004-06-23
CL2004001372A1 (es) 2005-05-06
GB0125081D0 (en) 2001-12-12
TNSN04067A1 (en) 2006-06-01
US20040259846A1 (en) 2004-12-23
JP2005521636A (ja) 2005-07-21

Similar Documents

Publication Publication Date Title
HK1066011A1 (en) Pharmaceutically acceptable alendronate salts in amorphous form
HUS000494I2 (hu) Tenofovir alafenamid vagy sója, elõnyösen tenofovir alafenamid fumarát
PL364223A1 (en) Pharmaceutical salts
AUPQ750500A0 (en) A power supply
IL153882A0 (en) Valsartan salts
NO20022822D0 (no) Kraftforsyningssystem for en brönn
AU2599701A (en) A 3d camera
AU2001230477A1 (en) Active aid for a handheld camera
AU2003214024A1 (en) A 3d track ball system
HK1064094A1 (en) Novel anticonvulsant derivative salts
AU2001253027A8 (en) A hybrid tracking system
PL373794A1 (en) New salts
AU2003227517A1 (en) Pharmacologically active salts
AUPQ787500A0 (en) A power supply altering means
AU2002213049A1 (en) Generating an order plan for a supply chain network
IL144444A0 (en) New morpholinobenzamide salts
AU1046401A (en) Device for positioning a videoprojector used in back projection
AU2001230213A1 (en) Power supply unit for a decentralized power supply
GB0204683D0 (en) Pharmaceutical salts
GB0206708D0 (en) Pharmaceutical salts
TW555276U (en) A polarized superfluorescent fiber source configuration
AU2002328828A1 (en) Calcium salts with cytotoxic activity
AU2002247745B2 (en) Pharmaceutical salts
AU2003245228A1 (en) Maleate salts
AU2002363009A1 (en) Generator for a hydro-electric station